Cartesian Therapeutics (RNAC) EBITDA Margin Growth (1y) (2016 - 2026)
Cartesian Therapeutics (RNAC) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cartesian Therapeutics | 226.07 Mn | 226.07 Mn | - | -3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.20 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Mar 31, 2025 | -176,135.00 |
| Dec 31, 2024 | 363,702.00 |
| Jun 30, 2024 | 39,643.00 |
| Mar 31, 2024 | 8,099.00 |
| Dec 31, 2023 | -38,895.00 |
| Sep 30, 2023 | -19,171.00 |
| Jun 30, 2023 | -39,037.00 |
| Mar 31, 2023 | -34,123.00 |
| Dec 31, 2022 | -6,421.00 |
| Sep 30, 2022 | 34.00 |
| Jun 30, 2022 | 3,299.00 |
| Mar 31, 2022 | 9,646.00 |
| Dec 31, 2021 | 7,971.00 |
| Sep 30, 2021 | 28,755.00 |
| Dec 31, 2020 | 12,282.00 |
| Dec 31, 2019 | 141,674.00 |
| Dec 31, 2018 | 11.18 Mn |
| Dec 31, 2017 | -11.29 Mn |